Zdravotníctvo
Antiviral Drug Discovery & Development Conference to Feature Big Pharma Advances in Respiratory/Influenza, HIV, & HBV/HCV in March, in Princeton, NJ
PRINCETON, N.J., USA (PROTEXT) - A major new, internationalconference presenting the newest advances by the pharmaceuticalindustry in developing novel drugs to fight viral diseases,including respiratory/influenza, HIV, and hepatitis B & C, willtake...
Zadavatel:
Antibiotic Compounds in Phase II/III Trials to Be Featured at Antibacterial Drug Discovery & Development Conference on March 13-14, 2000, in Princeton, NJ
PRINCETON, N.J. (PROTEXT) - Late-stage antibacterial compoundsin clinic will be featured at the "5th InternationalAntibacterial Drug Discovery & Development Summit" on March 13-14, 2000 at the Hyatt Regency Hotel in Princeton, NJ, announcesStrategic...
Zadavatel:
PharmaSoft získala velkou softwarovou zakázku od farmaceutické společnosti Fresenius, uvádí nový oceňovací model
UPPSALA (Švédsko) 17. prosince (PROTEXT/ots) - Přednímezinárodní farmaceutická softwarová společnost PharmaSoftzískala velkou zakázku od farmaceutické společnosti FreseniusKabi na Drug Watch, což je softwarový produkt pro analýzu aprezentaci medicínských...
Zadavatel:
Genome Therapeutics Adds New President and Chief Operating Officer / Appoints Dr. Richard D. Gill, Former General Manager of BTG plc's North American Operations
WALTHAM, Mass. (PROTEXT) - Genome Therapeutics Corp. (Nasdaq:GENE), a leader in the field of genomics, today announced theappointment of Richard D. Gill, Ph.D., as President and ChiefOperating Officer, effective January 3, 2000. Dr. Gill succeedsRobert...
Zadavatel:
Bristol-Myers Squibb and OXiGENE Announce Research and Licensing Agreement For Combretastatin Anti-Tumor Agents / Novel Compounds Target Blood Vessels Necessary
PRINCETON, N.J., BOSTON, and STOCKHOLM, Sweden (PROTEXT) -Bristol-Myers Squibb Company (NYSE: BMY) and OXiGENE, Inc.(Nasdaq: OXGN; Sweden) today announced an exclusive licensingagreement and research collaboration to develop and commercializecombretastatin...
Zadavatel:
Switzerland Is the First Country to Give Market Approval for Visudyne Therapy for AMD
ATLANTA and VANCOUVER, British Columbia (PROTEXT) - CIBAVision, the eye care unit of Novartis, and QLT PhotoTherapeuticsInc. (Nasdaq: QLTI; Toronto) announced today that the SwissRegulatory Agency -- Interkantonale Kontrollstelle für Heilmittel-- has...
Zadavatel:
Hemispherx Announces New Approach to HIV-Inhibition / Test Results Show Potential Advantages of Ampligen(R) as Anti-HIV Agent
Philadelphia (PROTEXT) - Hemispherx Biopharma, Inc. (Amex:HEB; HEBws) today announced that recent independent laboratorytest results show potential advantages of its product Ampligen(R)as an anti-HIV agent. According to findings presented today at the...
Zadavatel:
Společnost Bioheart, Inc. [a.s.] se bude prezentovat na konferenci o kardiovaskulární genomice, která se bude konat ve dnech 31. ledna a 1. února 2000 v Miami n
Weston, Florida (PROTEXT) - Bioheart, Inc.(www.bioheartinc.com), společnost, která se zaměřuje naprevenci a léčbu infarktu myokardu, se bude prezentovat nakonferenci v Miami, pořádané ve dnech 31. ledna a 1. února 2000. Společnost se specializuje na...
Zadavatel:
Rada pro prevenci epidemické hepatitidy (VIRAL HEPATITIS PREVENTION BOARD, VHPB) doporučuje evropským obcím s opakovaným výskytem epidemií, aby zvážily univerzá
ANTVERPY 13. prosince (PROTEXT/PRNewswire) - Rada proprevenci epidemické hepatitidy (Viral Hepatitis Prevention Board,VHPB), nezávislá poradenská skupina pro epidemickou hepatitidu,doporučuje, aby evropské obce, v nichž je výskyt hepatitidy Apodstatně...
Zadavatel:
Safety and Efficacy of Herceptin + Chemotherapy Further Supported by Studies Presented at Breast Cancer Conference
SAN ANTONIO (PROTEXT) - New advances in the study ofHerceptin(R) (trastuzumab), when used in combination with commonchemotherapies for the treatment of advanced (metastatic) breastcancer, were highlighted in two presentations at the 22nd AnnualSan Antonio...
Zadavatel:
ICN's Motion for Summary Judgment Continued for Six Months / Company Notes Insider Trading Allegations Against Chairman Were Never Claimed David Watt, ICN Offic
COSTA MESA, Calif. (PROTEXT) - ICN Pharmaceuticals, Inc.(NYSE: ICN) and Milan Panic announced today that they wouldproceed expeditiously to conduct discovery in response to aDecember 8, 1999, court order continuing for six months theirmotion for summary...
Zadavatel:
Zila to Market Swab Version of OraTest Product / Scheduled to Join Rinse Version in China in January 2000
London (PROTEXT) - Zila Europe, a division of Zila, Inc.(Nasdaq: ZILA), international provider of healthcare products fordental/medical professionals and consumers, announced that itwill introduce new OraTest(R) Swab, a variation of Zila'sOraTest(R)...
Zadavatel:
GE Marquette Medical Systems and Critikon Sign Agreement to Form Global Alliance / Companies Join to Support a $2.2 Billion Global Patient Monitoring Market
Tampa, Fla. and Milwaukee (PROTEXT) - Critikon Company LLC andGE Marquette Medical Systems (NYSE: GE) announced today that thecompanies have agreed to form a global alliance to jointlydevelop and distribute patient monitoring equipment and suppliesused...
Zadavatel:
HIV, Flu & HBV/HCV Focus of Antiviral Drug Discovery Conference on March 15-16, 2000, in New Jersey
Princeton, New Jersey (PROTEXT) - Pharmaceutical industryadvances in the discovery and development of novel antiviralagents in HIV, influenza/respiratory, and hepatitis B & C, willbe presented in depth on March 15-16, 2000 at the Hyatt RegencyHotel...
Zadavatel:
Global Enhancing Care Initiative Develops Comprehensive Framework To Improve HIV/AIDS Care in Resource-Poor Countries
Paris (PROTEXT) - Local Experts Join Together to Improve theLevels of Care and Provide Long-Term, Sustainable Solutions. A new nine-point AIDS care framework which outlines acomprehensive approach to enhance HIV/AIDS care within resource-poor regions...
Zadavatel:
Global Enhancing Care Initiative Develops Comprehensive Framework To Improve HIV/AIDS Care in Resource-Poor Countries
Paris (PROTEXT) - Local Experts Join Together to Improve theLevels of Care and Provide Long-Term, Sustainable Solutions. A new nine-point AIDS care framework which outlines acomprehensive approach to enhance HIV/AIDS care within resource-poor regions...
Zadavatel:
Bill a Melinda Gatesovi a Ted Turner přispějí 78 milióny dolarů na urychlení kampaně k vymýcení obrny do konce roku 2000
ŽENEVA 7. prosince (PROTEXT/ots-PRNewswire) - Finanční darypomohou podpořit kampaň Světové zdravotnické organizace (WHO),společnosti Rotary International a Dětského fondu OSN (UNICEF),jejímž cílem je získat 400 miliónů dolarů na definitivníodstranění...
Zadavatel:
Nelson Mandela, Bill Gates to Address Global Health Challenges
Seattle, Washington (ots-PRNewswire) - Leaders Expected toUrge Businesses, Governments and Philanthropists to Help ImproveAccess to Medical Advances for Developing Nations 1999 Former South African President Nelson Mandela will join BillGates, co-founder...
Zadavatel:
Domain Pharma Corporation a Integrated Clinical Systems, Inc. ohlásily na prosinec 1999 přístupnost webové verze Integrated Review
LEXINGTON (Mass.) 2. prosince (PROTEXT/ots) - JReview(TM)rozšiřuje přístup ke klinickým datům prostřednictvím Webu. Domain Pharma Corporation, přední světový poskytovatelsoftwaru pro řízení klinických zkoušek a regulačních dat, aIntegrated Clinical Systems,...
Zadavatel:
Abbott Laboratories Receives European Commission Marketing Authorization For Reformulated Norvir(R) (Ritonavir) Capsules
ABBOTT PARK, Ill. (PROTEXT) - Abbott Laboratories announcedtoday it has received marketing authorization from the EuropeanCommission for Norvir(R) (ritonavir) soft capsules. Norvir is aprotease inhibitor indicated in combination with otherantiretroviral...
Zadavatel: